{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:12:20Z","timestamp":1755216740077,"version":"3.43.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:p>Sinusoidal obstruction syndrome (SOS), formerly veno-occlusive disease (VOD), in pediatric cancer patients often presents as a complication of hematopoietic stem cell transplantation, and less commonly secondary to nontransplant-associated chemotherapy. Therapy with defibrotide is well-described as standard care for transplant-associated SOS\/VOD, but the treatment of nontransplant-associated SOS\/VOD is less clear. We report a 3-year-old with relapsed Wilms tumor and recurrent SOS\/VOD, with successful use of defibrotide during chemotherapy. A review of pediatric cancer patients with nontransplant-associated SOS\/VOD treated with defibrotide revealed 83 patients, and 66 were in remission. This review supports early treatment with defibrotide in patients with nontransplant-associated SOS\/VOD.<\/jats:p>","DOI":"10.1097\/mph.0000000000002177","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:06:32Z","timestamp":1619481992000},"page":"e788-e791","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of Sinusoidal Obstruction Syndrome With Defibrotide in Pediatric Cancer Patients Following Nontransplant-associated Chemotherapy: A Case Report and Review of the Literature"],"prefix":"10.1097","volume":"44","author":[{"given":"Marc R.","family":"Lawrence","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Ottawa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myl\u00e8ne","family":"Bassal","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Ottawa"},{"name":"Division of Hematology\/Oncology, Children\u2019s Hospital of Eastern Ontario, Ottawa, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raveena","family":"Ramphal","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Ottawa"},{"name":"Division of Hematology\/Oncology, Children\u2019s Hospital of Eastern Ontario, Ottawa, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna L.","family":"Johnston","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Ottawa"},{"name":"Division of Hematology\/Oncology, Children\u2019s Hospital of Eastern Ontario, Ottawa, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,4,26]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/11531840-000000000-00000","article-title":"Hepatic veno-occlusive disease: a chemotherapy-related toxicity in children with malignancies","volume":"12","author":"Cefalo","year":"2010","journal-title":"Paediatr Drugs"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"e27269","DOI":"10.1002\/pbc.27269","article-title":"Defibrotide for the treatment of hepatic veno\u2010occlusive disease\/sinusoidal obstruction syndrome following nontransplant\u2010associated chemotherapy: final results from a post hoc analysis of data from an expanded\u2010access program","volume":"65","author":"Kernan","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R3-20250804","first-page":"S113","article-title":"Treatment of stage II-IV diffuse anaplastic Wilms tumor: results from the Children\u2019s Oncology Group AREN0321 Study","volume":"61","author":"Daw","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1097\/MPH.0000000000000958","article-title":"Sinusoidal obstruction syndrome during chemotherapy of pediatric cancers and its successful management with defibrotide","volume":"39","author":"Kizilocak","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"e26963","DOI":"10.1002\/pbc.26963","article-title":"Venoocclusive disease due to chemotherapy for pediatric acute lymphoblastic leukemia is associated with increased levels of plasminogen-activator inhibitor-1","volume":"65","author":"Mauro","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/MPH.0b013e3182a8f352","article-title":"Hepatic sinusoidal obstruction syndrome during chemotherapy for childhood medulloblastoma: report of a case and review of the literature","volume":"36","author":"Kotecha","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"e27036","DOI":"10.1002\/pbc.27036","article-title":"\u201cPre-emptive strike\u201d-the case for early treatment of hepatic sinusoidal obstruction syndrome with defibrotide","volume":"65","author":"Rajagopal","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.4143\/crt.2016.096","article-title":"Severe hepatic sinusoidal obstruction syndrome in a child receiving vincristine, actinomycin-D, and cyclophosphamide for rhabdomyosarcoma: successful treatment with defibrotide","volume":"48","author":"Choi","year":"2016","journal-title":"Cancer Res Treat"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3109\/08923970903095322","article-title":"Hepatic veno-occlusive disease during chemotherapy for nephroblastoma: successful and safe treatment with defibrotide. Report of a clinical case","volume":"31","author":"Cecinati","year":"2009","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/pbc.22841","article-title":"Veno-occlusive disease in pediatric patients affected by Wilms tumor","volume":"57","author":"Cesaro","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4103\/ijmpo.ijmpo_188_16","article-title":"Sinusoidal obstruction syndrome during treatment for Wilms\u2019 tumor: a life-threatening complication","volume":"38","author":"Totadri","year":"2017","journal-title":"Indian J Med Paediatr Oncol"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/S2352-3026(19)30201-7","article-title":"Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement","volume":"7","author":"Mahadeo","year":"2020","journal-title":"Lancet Haematol"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41375-018-0265-z","article-title":"Inotuzumab ozogamicin in pediatric patients with relapsed\/refractory acute lymphoblastic leukemia","volume":"33","author":"Bhojwani","year":"2019","journal-title":"Leukemia"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/pbc.22202","article-title":"Veno-occlusive disease as a complication of preoperative chemotherapy for Wilms tumor: a clinico-pathological analysis","volume":"53","author":"Jagt","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1182\/blood-2009-07-230656","article-title":"Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children\u2019s Oncology Group CCG-1952 clinical trial","volume":"115","author":"Stork","year":"2010","journal-title":"Blood"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1182\/blood-2015-10-676924","article-title":"Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure","volume":"127","author":"Richardson","year":"2016","journal-title":"Blood"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/pbc.20338","article-title":"Veno-occlusive disease of the liver in a child after chemotherapy for brain tumor","volume":"46","author":"Elli","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11060-009-9996-z","article-title":"Hepatic sinusoidal obstruction syndrome in a child after chemotherapy for medulloblastoma","volume":"97","author":"Ishaqi","year":"2010","journal-title":"J Neurooncol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:13:21Z","timestamp":1754338401000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,26]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002177","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2021,4,26]]},"assertion":[{"value":"2020-11-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}